Angiogenic gene modification of skeletal muscle cells to compensate for ageing‐induced decline in bioengineered functional muscle tissue

Abstract

This pilot study showed that there was an age-related decline in the size and function of bioengineered muscle; however, there was an improvement in volume and function when the muscle cells were expressing VEGF.